Form 4: MiNK Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Brian Corvese, a Director of MiNK Therapeutics, Inc., received 1,633 shares of common stock on September 1, 2026.
Summary
- Grant/award: acquired 1,633 Common Stock at $10.95 ($17,881) on September 1, 2026; holds 54,770 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Brian Corvese — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Common Stock | 1,633 | $11 | $17.9K | 54,770 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (1,633 shares) |
Keywords
insider transaction, Form 4, INKT, MiNK Therapeutics, Inc., neutral, Brian Corvese
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.